Logo 13 Oct 2025

New clinical trial reg provides path to commercialization for Chinese biomedical tech

Subscribe to keep reading.

Sign up to stay briefed on what the Chinese government is doing, thinking, and saying.

Try it free

Already a subscriber? Log in.

China's new regulation on trialing biomedical technology – approved by the State Council last month and released in full on Friday – provides a clear path from clinical trials to widespread application for the first time. The reg covers frontier biomedical technologies like:

Cell and gene therapies...



More recent developments

Logo April 23, 2026
Innovators to get greater protection from the courts

What happened: On April 17, the Supreme People's Court (SPC) released a five-year plan to improve legal proceedings related to intellectual property disputes by 2030. The overall premise of the plan is interesting: It states that a key role of… Read More »

Logo April 22, 2026
Beijing launches new round of upgrades for electronic logistics documents

What happened: On April 17, China's cyberspace regulator (CAC) and nine other agencies — including the central bank (PBoC), Customs (GAC), and the tax authority (STA) — published regulations to promote and standardize electronic bills of lading, warehouse receipts, and… Read More »

Logo April 22, 2026
Beijing nudges SOEs to adopt agentic AI

What happened: On April 21, the State Council released opinions to promote high-quality development of the services sector. What caught our eye: the document calls for: “Accelerating the development and adoption of smart programming tools and supporting the procurement of… Read More »